JBAVX
Price
$32.79
Change
+$0.01 (+0.03%)
Updated
Dec 2 closing price
Net Assets
6.34B
RLBAX
Price
$39.31
Change
+$0.07 (+0.18%)
Updated
Dec 2 closing price
Net Assets
271.11B
Interact to see
Advertisement

JBAVX vs RLBAX

Header iconJBAVX vs RLBAX Comparison
Open Charts JBAVX vs RLBAXBanner chart's image
JHancock Balanced R5
Price$32.79
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets6.34B
American Funds American Balanced R1
Price$39.31
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets271.11B
JBAVX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
JBAVX vs. RLBAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBAVX is a StrongBuy and RLBAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 271B vs. JBAVX (6.34B). JBAVX pays higher dividends than RLBAX: JBAVX (1.76) vs RLBAX (1.07). JBAVX was incepted earlier than RLBAX: JBAVX (17 years) vs RLBAX (24 years). RLBAX (1.31) is less costly to investors than JBAVX (0.68). JBAVX is a more actively managed with annual turnover of: 67.00 vs. RLBAX (44.00). JBAVX has a lower initial minimum investment than RLBAX: JBAVX (0) vs RLBAX (250). JBAVX annual gain was more profitable for investors over the last year : 12.09 vs. RLBAX (8.44). JBAVX return over 5 years is better than : 46.27 vs. RLBAX (34.78).
JBAVXRLBAXJBAVX / RLBAX
Total Expense Ratio0.671.3151%
Annual Report Gross Expense Ratio0.681.3152%
Fund Existence17 years24 years-
Gain YTD15.90815.776101%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.34B271B2%
Annual Yield % from dividends1.761.07165%
Returns for 1 year12.098.44143%
Returns for 3 years47.0837.26126%
Returns for 5 years46.2734.78133%
Returns for 10 years103.2666.67155%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKDNX207.03N/A
N/A
Franklin DynaTech A
FBTDX162.25N/A
N/A
Franklin Biotechnology Discovery C
ACAYX61.37N/A
N/A
Alger Capital Appreciation Instl Y
PICOX50.73N/A
N/A
Putnam International Small Cap R6
LFFLX15.77N/A
N/A
Lord Abbett Focused Large Cap Value F